Gonadorelin

Gonadorelin — Gonadotropin-Releasing Hormone for Reproductive Endocrine Research

Gonadorelin (GnRH, LHRH) is a synthetic decapeptide identical to endogenous gonadotropin-releasing hormone, the master hypothalamic regulator of the reproductive axis. First sequenced by Nobel laureates Andrew Schally and Roger Guillemin in 1971, gonadorelin (pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂) has served as the cornerstone research tool for studying hypothalamic-pituitary-gonadal (HPG) axis physiology for over five decades. Its well-characterized pharmacology and dual agonist/desensitization biology make it indispensable for researchers investigating reproductive endocrinology, fertility, and neuroendocrine signaling.

Mechanism of Action

Gonadorelin binds the GnRH receptor (GnRHR) on anterior pituitary gonadotroph cells, a Gq/11-coupled GPCR that activates phospholipase C, generating IP3 and diacylglycerol second messengers. This triggers calcium mobilization from endoplasmic reticulum stores and PKC activation, resulting in exocytosis of LH and FSH from secretory granules. Critically, the biological response to GnRH is frequency-dependent: pulsatile administration (every 60-120 minutes) sustains gonadotropin secretion, while continuous exposure causes GnRHR internalization, desensitization, and paradoxical gonadotropin suppression—a phenomenon exploited in both research and clinical contexts.

Key Research Areas

• HPG Axis Assessment: Gonadorelin remains the standard provocative agent for pituitary gonadotroph function testing, enabling researchers to differentiate between hypothalamic and pituitary causes of hypogonadism by measuring LH/FSH release kinetics following bolus administration.
• Pulsatile vs. Continuous Signaling: The frequency-dependent response to GnRH is a paradigm in receptor biology. Researchers use gonadorelin in pulsatile delivery systems to study differential activation of LH-β versus FSH-β gene transcription, mediated by distinct MAPK signaling dynamics (ERK1/2 oscillation patterns).
• Fertility Research: Studies have demonstrated that pulsatile gonadorelin administration restores ovulatory cycles in hypothalamic amenorrhea models and normalizes spermatogenic function in hypogonadotropic animal models, maintaining physiological gonadotropin patterns.
• Receptor Desensitization Biology: Continuous gonadorelin exposure provides a model system for studying GPCR downregulation, β-arrestin-mediated internalization, and receptor recycling dynamics relevant to both reproductive and broader receptor pharmacology research.

Technical Specifications

• Dosage per vial: 2mg lyophilized powder
• Purity: ≥98% (HPLC verified)
• Sequence: pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂
• Molecular Weight: 1,182.31 Da
• Storage: -20°C, protected from light

Why Researchers Choose Peptides BioLab

Every batch of Gonadorelin supplied by Peptides BioLab undergoes rigorous HPLC and mass spectrometry analysis, ensuring ≥98% purity verified by an independent Certificate of Analysis (CoA). Our product is supplied as a lyophilized powder for maximum stability, shipped worldwide in temperature-controlled packaging.

Related Research Peptides

Researchers studying reproductive endocrinology may also find these compounds relevant: Kisspeptin, PT-141, and Testagen. For a complete overview, browse our Fertility Research collection.

For research purposes only — Not for human consumption. All products are intended solely for in-vitro research and laboratory use.